App aims to unlock words after stroke

NCT ID NCT07570264

Recruiting now Symptom relief Sponsor: Nunaps Inc Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests if a digital app called LEXURE can improve language skills in people who have trouble speaking after a stroke (aphasia). About 116 adults who had a stroke at least 3 months ago will either use the app or do workbook exercises. The goal is to see if the app helps them speak better after 10 weeks.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for APHASIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aphasia stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

APHASIA

Contacts and locations

Locations

Asan Medical Center
RECRUITING

Seoul, 05505, South Korea
Chonnam National University Hospital
RECRUITING

Gwangju, 61469, South Korea
Hallym University Chuncheon Sacred Heart Hospital
RECRUITING

Chuncheon, 24253, South Korea
Inje University Busan Paik Hospita
RECRUITING

Busan, 47392, South Korea
Inje University Ilsan Paik Hospital
RECRUITING

Ilsan, 10380, South Korea
Jeonbuk National University Hospital
NOT_YET_RECRUITING

Jeonju, 54907, South Korea
Keimyung University Dongsan Hospital
RECRUITING

Daegu, 42601, South Korea
Konkuk University Medical Center
RECRUITING

Seoul, South Korea
Korea University Ansan Hospital
NOT_YET_RECRUITING

Ansan, Gyeonggi-do, 15355, South Korea
Kyungpook National University Hospital
NOT_YET_RECRUITING

Daegu, 41944, South Korea
Ulsan University Hospital
RECRUITING

Ulsan, 44033, South Korea
Yeungnam University Medical Center
NOT_YET_RECRUITING

Daegu, 42415, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.